Assembly Biosciences (ASMB) EBIAT (2016 - 2025)
Historic EBIAT for Assembly Biosciences (ASMB) over the last 10 years, with Q3 2025 value amounting to -$9.2 million.
- Assembly Biosciences' EBIAT rose 433.79% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.5 million, marking a year-over-year increase of 553.13%. This contributed to the annual value of -$40.2 million for FY2024, which is 3438.13% up from last year.
- Assembly Biosciences' EBIAT amounted to -$9.2 million in Q3 2025, which was up 433.79% from -$10.2 million recorded in Q2 2025.
- In the past 5 years, Assembly Biosciences' EBIAT registered a high of -$8.8 million during Q1 2025, and its lowest value of -$60.3 million during Q4 2021.
- Over the past 4 years, Assembly Biosciences' median EBIAT value was -$11.2 million (recorded in 2024), while the average stood at -$17.3 million.
- Per our database at Business Quant, Assembly Biosciences' EBIAT crashed by 46145.12% in 2021 and then skyrocketed by 5210.03% in 2024.
- Over the past 4 years, Assembly Biosciences' EBIAT (Quarter) stood at -$60.3 million in 2021, then surged by 81.81% to -$11.0 million in 2023, then grew by 5.72% to -$10.3 million in 2024, then increased by 11.02% to -$9.2 million in 2025.
- Its EBIAT stands at -$9.2 million for Q3 2025, versus -$10.2 million for Q2 2025 and -$8.8 million for Q1 2025.